These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2242999)

  • 1. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
    Hikichi T; Kado M; Yoshida A
    Retina; 2000; 20(2):195-8. PubMed ID: 10783954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas.
    Kang SW; Hyung SM; Choi MY; Lee J
    Korean J Ophthalmol; 1995 Dec; 9(2):69-78. PubMed ID: 8818320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental model of preretinal neovascularization in the rabbit.
    Antoszyk AN; Gottlieb JL; Casey RC; Hatchell DL; Machemer R
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):46-52. PubMed ID: 1987106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase.
    Harooni M; McMillan T; Refojo M
    Retina; 1998; 18(1):16-22. PubMed ID: 9502276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal recombinant human erythropoietin: a safety study in rabbits.
    Song BJ; Cai H; Tsai JC; Chang S; Forbes M; Del Priore LV
    Curr Eye Res; 2008 Sep; 33(9):750-60. PubMed ID: 18798078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.
    Bakri SJ; Pulido JS; Mukherjee P; Marler RJ; Mukhopadhyay D
    Retina; 2008 Jan; 28(1):147-9. PubMed ID: 18185152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of the photosensitizer NPe6 following intravitreal injection.
    El-Dessouky ES; Moshfeghi AA; Peyman GA; Yoneya S; Mori K; Kazi AA; Moshfeghi DM
    Ophthalmic Surg Lasers; 2001; 32(4):316-21. PubMed ID: 11475398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye.
    Kinnunen K; Kalesnykas G; Mähönen AJ; Laidinen S; Holma L; Heikura T; Airenne K; Uusitalo H; Ylä-Herttuala S
    J Gene Med; 2009 May; 11(5):382-9. PubMed ID: 19263462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
    Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal toxicity of indocyanine green in albino rabbits.
    Goldstein M; Zemel E; Loewenstein A; Perlman I
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2100-7. PubMed ID: 16639021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
    Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes.
    Kosnosky W; Li TH; Pakalnis VA; Fox A; Hunt RC
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4260-7. PubMed ID: 8002246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.
    Kim SJ; Adams NA; Toma HS; Belair ML; Thorne JE; Green WR; Jabs DA
    Retina; 2008 Apr; 28(4):595-605. PubMed ID: 18398362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model of subretinal neovascularization in the rabbit.
    Kimura H; Sakamoto T; Hinton DR; Spee C; Ogura Y; Tabata Y; Ikada Y; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2110-9. PubMed ID: 7657549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.